Last reviewed · How we verify

NCT05163769

Physical and Cognitive Training System for Neurocognitive Protection and Enhancement in Older Adults

Status unknown NA Last updated 28 July 2022
What this trial tests

NA trial testing NeeuroCycle Physical and Cognitive Training System in Cognitive Decline in 237 participants. Status unknown.

Timeline
17 May 2022
Primary endpoint
30 September 2023
30 September 2023

Quick facts

Lead sponsorDuke-NUS Graduate Medical School
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment237
Start date17 May 2022
Primary completion30 September 2023
Estimated completion30 September 2023
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Duke-NUS Graduate Medical School

Who can join

Adults 50 to 75, any sex, with Cognitive Decline. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Neurocognitive decline is a health issue that is associated with ageing. It is often irreversible from the onset. The concomitant costs of neurocognitive decline could be potentially exponential if left unchecked. Therefore, there is a need to be able to delay the onset of age-related neurocognitive decline or possibly avoid it altogether. Previous studies have shown that there is a strong positive relationship between the fitness of neurocognitive function and cognitive training. More interestingly, recent studies also suggest that combining cognitive training with physical activity may result in a better outcome for neurocognitive function as compared to only cognitive training. Anchoring on the findings of those studies, the investigators aim to develop and evaluate the efficacy of a novel personalized multimodal brain computer interface (BCI) cognitive and physical training system for neurocognitive protection and enhancement in older adults. The current study employs a three-arm randomized-controlled trial approach. The investigators hypothesize that participants in the multimodal cognitive and physical training (mBCI) group will perform significantly better than the cognitive training-only BCI (nBCI) and active control (AC) groups on the Repeated Battery for the Assessment of Neuropsychological Status (RBANS) after an initial high-intensity 36 training session period from pre- to 12 weeks post-intervention. The investigators also hypothesize that the mBCI group will perform significantly better on the RBANS than nBCI or AC groups after the consecutive high- and low-intensity periods from pre- to 24-weeks post-intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cognitive Decline

Currently open trials in the same condition.

Other Duke-NUS Graduate Medical School trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05163769.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing